6 completed, 4 unknown. 4 Not applicable, 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 3, Unknown 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Severe Pre-eclampsia: new trials by email Literature Review of Severe Pre-eclampsia trials Research Report on Severe Pre-eclampsia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intravenous Labetalol vs Phentolamine for the Management of Severe Preeclampsia. Labetalol, Phentolamine - Severe Pre-eclampsia | Not applicable | Unknown | Assiut University | 200 | 2024-05-20 | 2024-04-26 |
| Pulmonary Edema Resolution in Severe Preeclampsia and Eclampsia Eclampsia, Severe Pre-eclampsia | Unknown | Doctors with Africa - CUAMM | 55 | 2023-05-08 | 2024-01-23 | |
| Comparison of Loading Dose Magnesium Sulphate With Prichard Regimen in the Management of Severe Preeclampsia and Eclampsia. Use of magnesium sulfate to prevent and stop fits in pre-eclampsia and Eclampsia - Severe Pre-eclampsia, Eclampsia | Not applicable | Completed | Federal Teaching Hospital Abakaliki | 120 | 2023-01-01 | 2023-11-13 |
| Serum Magnesium Concentration in Magnesium Sulfate Therapy for Severe Preeclampsia Severe Pre-Eclampsia | Completed | Mỹ Đức Hospital | 64 | 2022-03-15 | 2025-01-07 | |
| Ultrasonographic Diameter of Optic Nerve Sheath in Fluid Assessment in Severe Preeclamptic Patients ultrasound - Severe Pre-eclampsia | Unknown | Sohag University | 100 | 2021-12-06 | 2022-01-04 | |
| Nitroglycerin Versus Labetalol in Acute Severe Pre-eclampsia Labetalol and Glyceril trinitrate - Severe Pre-eclampsia | Not applicable | Completed | Ain Shams University | 200 | 2019-08-28 | 2022-04-05 |
| Serum Magnesium Level Administration in Severe Pre-eclampsia Obese Pregnancy Magnesium sulfate administration - Severe Pre-eclampsia, Magnesium Level | Not applicable | Completed | Department of Medical Services Ministry of Public Health of Thailand | 60 | 2018-09-30 | 2020-10-12 |
| Rosuvastatin in Order to Induce Preeclampsia Resolution in Severe PET up to 48 Hours Following Delivery Rosuvastatin, Placebo - Severe Pre-eclampsia | Phase 1 / Phase 2 | Unknown | Soroka University Medical Center | 100 | 2014-12-01 | 2014-12-11 |
| Evaluation of Metabolic Acid-base Abnormalities in Pre-eclamptic Women Applying the Stewart-Fencl Approach Mild Pre-eclampsia, Severe Pre-eclampsia | Completed | University of Washington | 120 | 2013-10-01 | 2014-10-15 | |
| Dexmedetomidine vs. Remifentanil for Pre-eclampsia During Caesarean Delivery Remifentanil, Dexmedetomidine - Pregnancy, Severe Pre-eclampsia | Phase 2 | Completed | Mansoura University | 50 | 2013-01-01 | 2017-01-23 |
Pre-Eclampsia (10) · Eclampsia (3) · Dyspnea (1) · Pulmonary Edema (1)
Female Urogenital Diseases and Pregnancy Complications (10) · Hypertension, Pregnancy-Induced (10) · Pregnancy Complications (10) · Urogenital Diseases (10) · Lung Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Respiration Disorders (1) · Respiratory Tract Diseases (1) · Signs and Symptoms (1) · Signs and Symptoms, Respiratory (1)
Labetalol (2) · AtpH protein, E coli (1) · Dexmedetomidine (1) · High-Energy Shock Waves (1) · Nitroglycerin (1) · Phentolamine (1) · Remifentanil (1) · Rosuvastatin Calcium (1) · halofantrine (1)
Ain Shams University (1) · Assiut University (1) · Department of Medical Services Ministry of Public Health of Thailand (1) · Doctors with Africa - CUAMM (1) · Federal Teaching Hospital Abakaliki (1) · Mansoura University (1) · Mỹ Đức Hospital (1) · Sohag University (1) · Soroka University Medical Center (1) · University of Washington (1)
Egypt (3) · Nigeria (1) · Sierra Leone (1) · South Africa (1) · Thailand (1) · United States (1) · Vietnam (1)
Adeniji Adetunji Oladeni (1) · Ehsan M Abdelaty, MD (1) · Eyad A Ramzy, MD (1) · Fathy Tash, MD (1) · Lan N Vuong, MD, PhD (1) · Luigi Pisani (1) · Samah El Kenany S, MD (1)